Using light therapy to reduce pain after dental surgery
Effect of Photobiomodulation to Reduce Post-operative Pain After Endodontic Surgery: a Randomized Controlled Clinical Trial
This study is testing if light therapy can help reduce pain for people recovering from dental surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Nove de Julho Academic / other |
| Locations | 1 site (Montevideo) |
| Trial ID | NCT05935306 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of photobiomodulation (FBM) in reducing postoperative pain for patients undergoing endodontic surgery. A total of 34 participants will be randomly assigned to either an experimental group receiving FBM or a control group receiving a simulation of the treatment. Both groups will also receive standard analgesia with ibuprofen as needed. The study will be double-blinded, ensuring that neither the patients nor the evaluators know which treatment is being administered, to maintain objectivity in assessing pain outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 70 with periapical lesions smaller than 10mm who have previously undergone endodontic treatment.
Not a fit: Patients with comorbidities, smokers, pregnant or lactating women, or those on certain medications affecting inflammation will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative pain for patients undergoing endodontic procedures.
How similar studies have performed: Previous studies have shown promising results for photobiomodulation in postoperative pain management, but this specific application in endodontic surgery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria :• Patients with periapical lesions who have already undergone endodontic treatment (lesions smaller than 10mm in their greatest diameter - Metin et al., 2018, single and chronic lesions) * Patients with not comorbidities, * Age from 18 to 70 years, * Both genders, * Healthy permanent teeth with good hygiene. Exclusion Criteria: * Who are taking drugs that affect bone metabolism and the inflammatory process (for example: corticosteroids, bisphosphonates), * Smokers, pregnant or lactating women, * Who used anti-inflammatory drugs in the last 3 months before surgery. * Who for any reason interrupted the evolution of the treatment for not attending joint appointments. * Patients who do not follow the guidelines or have an injury in the acute phase (pain, edema, exudate)
Where this trial is running
Montevideo
- Universidade Catolica do Uruguay — Montevideo, Uruguay (Recruiting)
Study contacts
- Study coordinator: Rolf Wilhem C Cirisola
- Email: drconsolandich@gmail.com
- Phone: 13981999848
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.